D. A. Berry
- Oncology top 10%
- Genetics top 10%
- Cancer Research top 10%
- Pathology and Forensic Medicine
- Molecular Biology
- Co-authors
- Giovanni ParmigianiEric P. WinerJulian SanchezJoellen SchildkrautC. CirrincioneClifford A. HudisTammy O. TengsAndrew D. Seidman
- Topics
- Breast Cancer Treatment Studies (8 papers)Cancer Treatment and Pharmacology (7 papers)Cancer Genomics and Diagnostics (6 papers)
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- United StatesItalyFrance
In The Last Decade
D. A. Berry
26 papers receiving 660 citations
Peers
Comparison fields: 5 of 61
- Oncology 307
- Genetics 279
- Cancer Research 261
- Pathology and Forensic Medicine 106
- Molecular Biology 105
Countries citing papers authored by D. A. Berry
This map shows the geographic impact of D. A. Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. Berry more than expected).
Fields of papers citing papers by D. A. Berry
This network shows the impact of papers produced by D. A. Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. Berry. The network helps show where D. A. Berry may publish in the future.
Co-authorship network of co-authors of D. A. Berry
This figure shows the co-authorship network connecting the top 25 collaborators of D. A. Berry. A scholar is included among the top collaborators of D. A. Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. A. Berry. D. A. Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 31 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 13 | |
| 6 | 1 | |
| 7 | 29 | |
| 8 | 11 | |
| 9 | 2 | |
| 10 | 4 | |
| 11 | 49 | |
| 12 | 16 | |
| 13 | 46 | |
| 14 | The cost effectiveness of testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes | 17 |
| 15 | 278 | |
| 16 | Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. | 52 |
| 17 | 5 | |
| 18 | 54 | |
| 19 | 8 | |
| 20 | 2 |
About D. A. Berry
D. A. Berry is a scholar working on Cancer Research, Oncology and Statistics and Probability, having authored 27 papers that have together received 695 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (261 citations), Oncology (307 citations) and Genetics (279 citations). D. A. Berry has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Giovanni Parmigiani, Eric P. Winer, Julian Sanchez, Joellen Schildkraut, C. Cirrincione, Clifford A. Hudis, Tammy O. Tengs, Andrew D. Seidman, L. G. Dressler and I. Craig Henderson. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.